Quotes for Respiratorius AB
Right Now
- +/-
- %
- 0,00%
- Latest
- High
- Low
- Volume
- 0
- Turnover (SEK)
- 0
- Market Value (MSEK)
- 97,6
- Time (Latest trade)
Board
CEO
- Johan Drott
Chairperson of the Board
- Karin Wehlin
Board
- Anna Törner
- Johan Drott
- Kristina Drott
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Avanza Pension | 8,28 | 8,28 | 2024-03-26 |
Valcuria Holding AB | 3,86 | 3,86 | 2024-03-26 |
Ben Hayes | 2,32 | 2,32 | 2024-03-26 |
Hans Harvig | 1,72 | 1,72 | 2024-03-26 |
Hans Mandahl | 1,20 | 1,20 | 2024-03-26 |
Benny Bengtsson | 1,09 | 1,09 | 2024-03-26 |
Göran Lennart Rehn | 0,99 | 0,99 | 2024-03-26 |
Hartmut Wiese | 0,99 | 0,99 | 2024-03-26 |
Christian Müller | 0,99 | 0,99 | 2024-03-26 |
Nordnet Pensionsförsäkring | 0,90 | 0,90 | 2024-03-26 |
2024-05-21 Årsstämma 2023
2024-05-21 Delårsrapport 2024-Q1
2024-08-06 Delårsrapport 2024-Q2
2024-11-12 Delårsrapport 2024-Q3
2025-02-11 Bokslutskommuniké 2024